Figure 3.
Figure 3. Model assessing clinical risk according to MYC and BCL2 Status in DLBCL. The risk of treatment failure is proportional to the degree of MYC and BCL2 expression. The 5% of patients with the poorest outcome are shown in red and have the highest level of MYC and BCL expression as a result of translocation immunoglobulin loci. Reprinted from Sesques and Johnson75 with permission.

Model assessing clinical risk according to MYC and BCL2 Status in DLBCL. The risk of treatment failure is proportional to the degree of MYC and BCL2 expression. The 5% of patients with the poorest outcome are shown in red and have the highest level of MYC and BCL expression as a result of translocation immunoglobulin loci. Reprinted from Sesques and Johnson75  with permission.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal